ClinicalTrials.Veeva

Menu

At-home Transcranial Alternating Current Stimulation During Multitasking

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Completed

Conditions

Multitasking Behavior

Treatments

Device: Transcranial alternating current stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04231825
18-26268-1

Details and patient eligibility

About

The goal is to replicate in-lab results from transcranial alternating current stimulation (tACS) with at-home tACS.

Full description

Participants will be assessed in-lab on multitasking and sustained attention abilities. Participants will be sent home with a tACS device to be used at-home for five days while engaged in a multitasking paradigm that is different from the multitasking outcome measure used pre/post tACS. After the at-home stimulation is complete, participants return to UCSF for a final in-lab assessment of multitasking and sustained attention ability.

Enrollment

47 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • English speaking
  • Grade 12 or more education
  • Normal or corrected to normal vision and hearing
  • Ability to complete cognitive tasks
  • Ability to cooperate and comply with all study procedures
  • Ability to tolerate tACS

Exclusion criteria

  • Neurological or psychiatric disorders
  • Family history of epilepsy
  • History of seizures
  • Prior head trauma
  • Pregnant
  • Implanted electronic devices (e.g., pacemaker)
  • IQ < 80
  • Taking psychotropic medication
  • Taking anti-depressants or anti-anxiety medication
  • Substance abuse
  • Color blind
  • Glaucoma
  • Macular degeneration
  • Amblyopia
  • Strabismus

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

47 participants in 2 patient groups

Verum Stimulation
Experimental group
Description:
This group will receive 6-Hz tACS
Treatment:
Device: Transcranial alternating current stimulation
Frequency Control
Active Comparator group
Description:
This group will receive 1-Hz tACS
Treatment:
Device: Transcranial alternating current stimulation

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems